Compass Therapeutics, Inc. (CMPX) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CMPXCompass Therapeutics, Inc.Follow CMPX — free
—
Price chart with a free account
- Market cap
- 137.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating margin | -6661.8% | — | — | |
| Net margin | -5808.8% | — | — | |
| FCF margin | -5282.2% | — | — |
USD millions · SEC XBRL
Every figure on this page comes from Compass Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.